Infection

Oragenics Project to Develop a Variant-Agnostic Protein Antigen for Use in its COVID-19 Intranasal Vaccine Receives Funding from CQDM

Retrieved on: 
Monday, June 5, 2023
COVID-19, Research, Infectious Diseases, Health Technology, Biotechnology, Health, Pharmaceutical, Other Science, Science, Antigen, SARS-CoV-2, NRC, CHO, Infection, Transport, Immunization, NYSE, National Research Council, Vaccine, Oragene

The project, which aims to build upon Oragenics’ current lead intranasal vaccine candidate NT-CoV2-1, is a collaboration with the National Research Council of Canada (NRC) and Inspirevax.

Key Points: 
  • The project, which aims to build upon Oragenics’ current lead intranasal vaccine candidate NT-CoV2-1, is a collaboration with the National Research Council of Canada (NRC) and Inspirevax.
  • The grant awarded by CQDM is expected to help Oragenics fund the development of two to four well-characterized stable CHO pools expressing new, cross-protective vaccine antigens with well-established preclinical efficacy using intranasal immunization.
  • The grant funding is awarded through SynergiQC, a Quebec-based funding program for biopharmaceutical research created by CQDM.
  • CQDM extends its funding capacity to the development of biopharmaceutical products with high industrial and commercial value, such as more competitive molecules and other technologies.

Insect Repellent Active Ingredients Market worth $1.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, June 9, 2023
Prevalence, Chikungunya, Dry, National library, Chemical substance, Telephone numbers in Hungary, Dengue fever, S. C. Johnson & Son, Region, Virus, Coghlan, Malaria, Anticoagulant, Lyme disease, Infection, USD, Death, Insect, Bacteria, Rat, Bed bug, PCR, Skin, Pest control, Tick, Parasitism, Agriculture, WHO, Comparison of birth control methods, Disease, Pellet, Clothing, Biting, Quality of life, Zika virus, DEET, Canine vector-borne disease, Medicine, Beauty salon, Mouse, Cockroach, Application, ZIKV, Form, Powder, Godrej

CHICAGO, June 9, 2023 /PRNewswire/ -- The Insect Repellent Active Ingredients Market is estimated at USD 1.0  billion in 2023 and is projected to reach USD 1.5 billion by 2028, at a CAGR of 7.6% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, June 9, 2023 /PRNewswire/ -- The Insect Repellent Active Ingredients Market is estimated at USD 1.0  billion in 2023 and is projected to reach USD 1.5 billion by 2028, at a CAGR of 7.6% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • As people become more aware of the health risks associated with insect bites, the demand for insect repellent products, and consequently, their active ingredients, has increased.
  • The insect repellent active ingredients market industry has been studied in North America, Europe, Asia Pacific, South America and Rest of the World.
  • These diseases pose significant health risks to the population, leading to a greater demand for insect repellent products and active ingredients to protect against insect bites.

Insect Repellent Active Ingredients Market worth $1.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, June 9, 2023
Prevalence, Chikungunya, Dry, National library, Chemical substance, Telephone numbers in Hungary, Dengue fever, S. C. Johnson & Son, Region, Virus, Coghlan, Malaria, Anticoagulant, Lyme disease, Infection, USD, Death, Insect, Bacteria, Rat, Bed bug, PCR, Skin, Pest control, Tick, Parasitism, Agriculture, WHO, Comparison of birth control methods, Disease, Pellet, Clothing, Biting, Quality of life, Zika virus, DEET, Canine vector-borne disease, Medicine, Beauty salon, Mouse, Cockroach, Application, ZIKV, Form, Powder, Godrej

CHICAGO, June 9, 2023 /PRNewswire/ -- The Insect Repellent Active Ingredients Market is estimated at USD 1.0  billion in 2023 and is projected to reach USD 1.5 billion by 2028, at a CAGR of 7.6% from 2023 to 2028 according to a report published by MarketsandMarkets™.

Key Points: 
  • CHICAGO, June 9, 2023 /PRNewswire/ -- The Insect Repellent Active Ingredients Market is estimated at USD 1.0  billion in 2023 and is projected to reach USD 1.5 billion by 2028, at a CAGR of 7.6% from 2023 to 2028 according to a report published by MarketsandMarkets™.
  • As people become more aware of the health risks associated with insect bites, the demand for insect repellent products, and consequently, their active ingredients, has increased.
  • The insect repellent active ingredients market industry has been studied in North America, Europe, Asia Pacific, South America and Rest of the World.
  • These diseases pose significant health risks to the population, leading to a greater demand for insect repellent products and active ingredients to protect against insect bites.

Morris Animal Foundation marks 75th anniversary, reflects on decades of advancing animal health research

Retrieved on: 
Thursday, June 8, 2023
Veterinary medicine, Horse, Morris Animal Foundation, Rutgers University, Vaccine, Health, Animal, Infection, Research, Dog, Iowa State University, Cat, Pharmaceutical industry

DENVER, June 8, 2023 /PRNewswire/ -- Morris Animal Foundation, a global leader in advancing animal health, is celebrating its 75th anniversary this month with June 15 declared as Morris Animal Foundation Day by Colorado Governor Jared Polis.

Key Points: 
  • DENVER, June 8, 2023 /PRNewswire/ -- Morris Animal Foundation, a global leader in advancing animal health, is celebrating its 75th anniversary this month with June 15 declared as Morris Animal Foundation Day by Colorado Governor Jared Polis.
  • The Foundation traces its roots back to 1948, when a forward-thinking veterinarian – Dr. Mark L. Morris Sr. – founded the organization to improve the health and well-being of animals everywhere.
  • As the Foundation celebrates its 75th anniversary, it reflects on its decades of work –  funding nearly 3,000 studies to date – and its continued push to advance veterinary medicine on a global scale.
  • Morris Animal Foundation through the years:
    In 1950, the Foundation funded its first two studies, which investigated cat and dog nutrition at Rutgers University and Iowa State University, respectively.

PCPLUS, the All-Inclusive Infection Prevention Program for Healthcare developed by UMF|PerfectCLEAN

Retrieved on: 
Thursday, June 8, 2023
CMS, Clostridioides difficile, Infection, Health, Electrolux, MRSA, SARS, EVS, Carbon, Ecosystem, CDC, EPA, Hospital, Patient, Risk, Blood, Disinfectant, APIC, Conference, Health insurance, Vaccine, Nursing, Norovirus, Bang Phai MRT station

NORTHBROOK, Ill., June 8, 2023 /PRNewswire/ -- UMF|PerfectCLEAN proudly introduces the new PCPLUS all-inclusive infection prevention program for healthcare. PCPLUS is a comprehensive program that integrates state-of-the-art, programmable Electrolux commercial laundry equipment; best-in-class hospital grade microfiber and hardware products; Klorese® sporicidal cleaner/disinfectant; a comprehensive training program; and a state of the art monitoring tool. The PCPLUS program provides hospitals with complete control over their infection prevention textile program. PCPLUS contributes to reducing preventable hospital associated infections (pHAIs) and achieving maximum environmental sustainability, all at a significant cost savings.

Key Points: 
  • NORTHBROOK, Ill., June 8, 2023 /PRNewswire/ -- UMF|PerfectCLEAN proudly introduces the new PCPLUS all-inclusive infection prevention program for healthcare.
  • The PCPLUS program provides hospitals with complete control over their infection prevention textile program.
  • "We developed the PCPLUS program based on feedback from our healthcare customers.
  • With PCPLUS, healthcare facilities reduce carbon dioxide emissions related to shipping; plastic waste from disposables and packaging; cardboard waste; and microplastic production.

Birmingham spinout to develop 20-minute test following surge in sexually transmitted infections

Retrieved on: 
Thursday, June 8, 2023
Infection, Linearity, National Institute for Health and Care Research, UK Health Security Agency, DNA, University, STI, MSM, Neisseria, Woman, Multimedia, Gonorrhea, University of Birmingham, Chlamydia trachomatis, Patient, Security agency, NIHR, World Health Organization, Vertically transmitted infection, Diagnosis, WHO, WSW, Birth control, Vaccine, Chlamydia

Brendan Farrell, Chairman of Linear Diagnostics, said: "For STIs, the rapidity of the testing procedure is key, as patients prefer to get test results quickly and start treatment immediately.

Key Points: 
  • Brendan Farrell, Chairman of Linear Diagnostics, said: "For STIs, the rapidity of the testing procedure is key, as patients prefer to get test results quickly and start treatment immediately.
  • Its work brings people from across the world to Birmingham, including researchers, teachers and more than 8,000 international students from over 150 countries.
  • The World Health Organization has noted the rapid increase in multi-drug resistant gonorrhoea, with all confirmed treatment failures except one being pharyngeal infections affecting the throat.
  • The UK Health Security Agency warned this week of a surge in gonorrhoea cases, with a 50% increase between 2021 and 2022.

Birmingham spinout to develop 20-minute test following surge in sexually transmitted infections

Retrieved on: 
Thursday, June 8, 2023
Infection, Linearity, National Institute for Health and Care Research, UK Health Security Agency, DNA, University, STI, MSM, Neisseria, Woman, Gonorrhea, University of Birmingham, Chlamydia trachomatis, Patient, Security agency, NIHR, World Health Organization, Vertically transmitted infection, Diagnosis, WHO, WSW, Vaccine, Chlamydia

The University of Birmingham is ranked amongst the world's top 100 institutions.

Key Points: 
  • The University of Birmingham is ranked amongst the world's top 100 institutions.
  • Its work brings people from across the world to Birmingham, including researchers, teachers and more than 8,000 international students from over 150 countries.
  • The World Health Organization has noted the rapid increase in multi-drug resistant gonorrhoea, with all confirmed treatment failures except one being pharyngeal infections affecting the throat.
  • The UK Health Security Agency warned this week of a surge in gonorrhoea cases, with a 50% increase between 2021 and 2022.

New "AI Doctor" Predicts Hospital Readmission and Other Health Outcomes

Retrieved on: 
Wednesday, June 7, 2023
Infection, Insurance, Human, Nature, Data science, Workflow, LLM, Sofinnova, Mirati Therapeutics, Health status of Asian Americans, NYU, Radiology, New York University Grossman School of Medicine, Woman, Nvidia, MBA, Research, Doctor of Philosophy, National Institutes of Health, Computer, Bachelor of Science, Language, Abbreviation, Judgement, Bangladesh Technical Education Board, NYU Langone Health, Hospital, Patient, Physician, Risk, New York University Center for Data Science, Artificial intelligence, AI, Health, Death, Health information management, Software, Medical device, Nursing, Pharmaceutical industry, MD, Neurosurgery

NEW YORK, June 7, 2023 /PRNewswire/ -- An artificial intelligence (AI) computer program can read physicians' notes to accurately estimate patients' risk of death, length of hospital stay, and other factors important to care. Designed by a team led by researchers at NYU Grossman School of Medicine, the tool is currently in use in its affiliated hospitals to predict the chances that a patient who is discharged will be readmitted within a month.

Key Points: 
  • Experts have long explored computer algorithms meant to improve healthcare, with some having been shown to make valuable clinical predictions.
  • "Since NYUTron reads information taken directly from the electronic health record, its predictive models can be easily built and quickly implemented through the healthcare system."
  • The terms and conditions of these arrangements are being managed in accordance with the policies and practices of NYU Langone Health.
  • Other study authors included Nima Pour Nejatian, PhD, MBA, at nVidia in Santa Clara, Calif., whose computer hardware was used to build NYUTron.

Prenosis Inc. Receives BARDA Contract to Study Utility of Its Sepsis Diagnostic Tool

Retrieved on: 
Wednesday, June 7, 2023
Infection, ASPR, Partnership, Society, Biomedical Advanced Research and Development Authority, Housing, Office of Inspector General, U.S. Department of Health and Human Services, HHS, Sepsis, HBD, Society of Critical Care Medicine, EMR, TED (conference), Human services, Administration for Strategic Preparedness and Response, Research, Electronic health record, Biomarker, American Thoracic Society, Administration, Plasma, Development, Hospital, Data, Patient, Physician, Risk, Medicine, Cancer, Biosafety, Entrepreneurship, American Association for Clinical Chemistry, FDA, Health, BARDA, Medtech, MDDI, Critical Care Medicine (journal), Medical device, Medical imaging, Pharmaceutical industry

CHICAGO, June 7, 2023 /PRNewswire/ -- Prenosis Inc., an artificial intelligence company enabling precision medicine in acute care, announced today it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), a U.S. government agency.

Key Points: 
  • Prenosis has built a large, rapidly growing dataset and biobank from patients with sepsis and other infections.
  • By leveraging its proprietary dataset and AI/ML techniques, Prenosis is creating precision medicine solutions, starting with a sepsis diagnostic tool.
  • Prenosis' Sepsis ImmunoScore™ intends to enable true precision medicine for infection in hospitals.
  • The Sepsis ImmunoScore™ is a pathogen-agnostic, host-based digital diagnostic (HBD) that uses clinical parameters and protein biomarkers to assess a patient's risk of sepsis within 24 hours.

Race, Ethnicity and Source of Payment Can Increase Patient Risk of Adverse Events in Hospitals

Retrieved on: 
Wednesday, June 7, 2023
Danforth, Approximation error, Database, Medicaid, Patient safety organization, Partnership, Accident, AARP, Hospital, Infection, Health care, Data collection, Sepsis, Medicare, Incidence, Urban Institute, Leapfrog, Patient, Risk, AHRQ, Respiratory failure, Safety, Injury, Pharmaceutical industry, Health insurance, Nursing, Grade

WASHINGTON, June 7, 2023 /PRNewswire/ -- The Leapfrog Group, a national nonprofit advancing the highest standards for patient safety in hospitals and ambulatory surgery centers, today published a report examining the association between Leapfrog Hospital Safety Grades and differences in rates of adverse safety events among white, Black and Hispanic patients and among patients with commercial insurance and public insurance such as Medicare or Medicaid. The analysis found that higher-graded hospitals are safer for all patients, but Black and Hispanic patients are still at increased risk of experiencing certain surgery-related adverse safety events when compared to white patients even at hospitals at all grade levels. The report, Racial, Ethnic and Payer Disparities in Adverse Safety Events: Are there Differences across Leapfrog Hospital Safety Grades, was developed in partnership with Urban Institute with funding from AARP.

Key Points: 
  • The analysis found that higher-graded hospitals are safer for all patients, but Black and Hispanic patients are still at increased risk of experiencing certain surgery-related adverse safety events when compared to white patients even at hospitals at all grade levels.
  • Hispanic patients experience:
    Across all hospitals, patients covered by Medicare or Medicaid experienced higher rates of adverse safety events when compared to patients covered by private insurance coverage.
  • "Hospitals should recognize these disparities and ensure resources are devoted to reducing adverse safety events among patient groups at the highest risk."
  • The report found that the Hospital Safety Grade accurately predicted which hospitals put patients most at risk for adverse events.